Life Sciences

Image of Asset web 2024 industries life sci hero 02
Image of Asset web 2024 industries life sci spiral 01

Innovate with AI and machine learning (ML)

To be competitive, organizations are investing in flexible, compliant data foundations that enable AI for table stakes and enterprise use cases.

Image of Asset web 2024 industries life sci hex 01

Realize the future of sales and experience

Organizations are adapting digital experiences, education, and technologies. The sales rep role requires AI-supported sales tools, predictive analytics, automation, IoT connectivity, and more.

Image of Asset web 2024 industries life sci ripple 01
Image of Asset web 2024 industries life sci leaves 01

Optimize the supply chain with generative AI

GenAI can enhance operational efficiency, reduce carbon footprint, and improve cost management. It refines clinical trial processes, reduces waste, and enhances demand-supply planning accuracy.

Image of Asset web 2024 industries life sci room blur 01

Meet demand for personalized medicine and biotech

Personalized medicine is expected to hit an anticipated $62.5B by 2032, which indicates a shift toward tailored treatments. Next-gen therapies that address a disease’s root causes are at the forefront.

Image of Asset web 2024 industries life sci sphere 01

Increase health equity

To accelerate global health equity, organizations can apply data-driven insights, partner with advocacy groups, foster internal alignment for implementation, and leverage the power of innovative technology.

2024 Slalom industry outlook: Life sciences

Tomorrow’s life sciences technology landscape

Image of Asset case study card cecilia health

Cecelia Health

Creating a smoother path for diabetes patients with a more efficient analytics platform

Image of Asset case study card sygnomics


A data-viz dashboard helps oncologists personalize treatment for better outcomes


Image of Asset web 2024 industries life sci hologic full 01

Detecting cervical cancer with ML for earlier treatment

Hologic is working to make life-saving cervical cancer screening faster, more accurate, and available to anyone around the world. Slalom Build helped bring this intelligent healthcare solution to life with ~70% sensitivity compared to human review.

Learn more




Approved by FDA

Hologic Genius™ is the first and only FDA-cleared digital cytology platform.



Reduction in false negatives

The Hologic Cervical AI algorithm improves sensitivity without decreasing specificity.



Increase in confidence rate

A Veripad model identifies counterfeit medications with 5-10% higher confidence than humans.

Our thinking in life sciences

More personalized care with wider reach. Sounds like a paradox, but it's achievable today. Operationalized AI in the form of intelligent products delivers more successful clinical trials, faster diagnoses, and better precision medicine.

Read on

Image of Asset intelligent products more rehuman 01

Our Technology Partners

Image of Asset web 2024 partners full 01

The industry’s best technology partnerships

Our partnerships with over 700 of the world’s leading technology providers help us fuel innovation and sustainable growth for our customers.

Explore our partners

Connect with us at Slalom Build for more info